NASDAQ:EGRX
$33.75
(
1.50%
)
Friday, 27th Jan 2023
Eagle Pharmaceuticals Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $27.97 | $34.22 | Friday, 27th Jan 2023 EGRX stock ended at $33.75. This is 1.5% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 6.04% from a day low at $32.27 to a day high of $34.22. |
| 90 days | $27.97 | $40.85 | |
| 52 weeks | $24.35 | $53.78 |
Historical Eagle Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $33.35 | $34.22 | $32.27 | $33.75 | 86 977 |
| 2023-01-26 | $32.73 | $33.34 | $32.32 | $33.25 | 219 410 |
| 2023-01-25 | $32.43 | $32.96 | $31.79 | $32.55 | 114 944 |
| 2023-01-24 | $33.42 | $33.59 | $32.72 | $32.78 | 87 291 |
| 2023-01-23 | $33.63 | $34.19 | $33.36 | $33.64 | 152 014 |
| 2023-01-20 | $33.72 | $34.19 | $32.42 | $33.91 | 149 700 |
| 2023-01-19 | $32.78 | $33.63 | $32.56 | $33.37 | 107 245 |
| 2023-01-18 | $32.84 | $33.55 | $32.25 | $32.79 | 141 300 |
| 2023-01-17 | $32.61 | $33.64 | $32.10 | $32.86 | 148 433 |
| 2023-01-13 | $33.10 | $33.74 | $31.97 | $32.45 | 163 000 |
| 2023-01-12 | $31.97 | $33.15 | $31.97 | $33.14 | 228 941 |
| 2023-01-11 | $30.60 | $32.01 | $30.43 | $31.92 | 148 407 |
| 2023-01-10 | $30.62 | $31.37 | $29.88 | $30.70 | 279 406 |
| 2023-01-09 | $30.57 | $30.95 | $29.86 | $30.74 | 157 530 |
| 2023-01-06 | $29.48 | $30.57 | $29.21 | $30.46 | 118 529 |
| 2023-01-05 | $30.05 | $30.05 | $28.77 | $29.26 | 95 568 |
| 2023-01-04 | $29.29 | $30.44 | $29.25 | $30.14 | 150 535 |
| 2023-01-03 | $29.18 | $29.85 | $28.83 | $29.23 | 124 934 |
| 2022-12-30 | $28.77 | $29.28 | $28.50 | $29.23 | 103 791 |
| 2022-12-29 | $28.30 | $29.48 | $28.30 | $28.98 | 110 777 |
| 2022-12-28 | $28.49 | $28.95 | $27.97 | $28.24 | 110 610 |
| 2022-12-27 | $29.15 | $29.18 | $28.40 | $28.51 | 99 321 |
| 2022-12-23 | $29.45 | $29.48 | $28.82 | $29.11 | 112 454 |
| 2022-12-22 | $29.69 | $29.89 | $29.00 | $29.53 | 117 135 |
| 2022-12-21 | $29.88 | $30.63 | $29.60 | $29.87 | 133 431 |
| 2022-12-20 | $29.95 | $30.39 | $29.48 | $29.64 | 190 373 |
| 2022-12-19 | $30.30 | $30.44 | $29.17 | $30.03 | 140 905 |
| 2022-12-16 | $29.13 | $29.78 | $28.92 | $29.33 | 671 245 |
| 2022-12-15 | $30.50 | $30.50 | $29.17 | $29.55 | 161 410 |
| 2022-12-14 | $31.01 | $31.68 | $30.29 | $30.70 | 139 450 |
| 2022-12-13 | $31.78 | $32.20 | $30.96 | $31.04 | 257 854 |
| 2022-12-12 | $31.27 | $32.33 | $30.36 | $31.27 | 220 098 |
| 2022-12-09 | $31.79 | $32.47 | $30.96 | $31.04 | 176 735 |
| 2022-12-08 | $31.86 | $32.84 | $31.47 | $31.77 | 156 465 |
| 2022-12-07 | $33.64 | $34.29 | $31.69 | $31.84 | 193 835 |
| 2022-12-06 | $34.03 | $34.55 | $33.64 | $33.76 | 149 260 |
| 2022-12-05 | $35.82 | $35.82 | $33.48 | $33.96 | 148 594 |
| 2022-12-02 | $35.16 | $35.93 | $34.89 | $35.91 | 83 540 |
| 2022-12-01 | $36.29 | $36.42 | $35.09 | $35.48 | 103 462 |
| 2022-11-30 | $35.55 | $36.39 | $34.36 | $36.32 | 207 505 |
| 2022-11-29 | $35.61 | $36.22 | $35.07 | $35.25 | 96 710 |
| 2022-11-28 | $35.65 | $36.55 | $35.30 | $35.69 | 90 583 |
| 2022-11-25 | $36.16 | $36.66 | $35.43 | $35.89 | 38 413 |
| 2022-11-23 | $36.92 | $37.51 | $36.26 | $36.55 | 71 589 |
| 2022-11-22 | $36.39 | $37.36 | $35.76 | $37.32 | 69 432 |
| 2022-11-21 | $37.59 | $37.78 | $36.03 | $36.03 | 49 199 |
| 2022-11-18 | $36.95 | $37.98 | $36.95 | $37.73 | 60 071 |
| 2022-11-17 | $36.05 | $36.83 | $35.80 | $36.69 | 32 675 |
| 2022-11-16 | $36.74 | $37.36 | $36.41 | $36.53 | 36 316 |
| 2022-11-15 | $37.22 | $38.49 | $36.59 | $37.21 | 53 494 |
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
